IRVINE, Calif., Oct. 20 /PRNewswire-FirstCall/ — Cardiogenesis
Corporation (OTCQB: CGCP) announced that the company will release
results for its third quarter ended September 30, 2010 on
Wednesday, November 3, 2010. The company added that Paul J.
McCormick, its Executive Chairman, and William R. Abbott, its
Senior Vice President and Chief Financial Officer, will host an
investor conference call that day at 5:00 p.m. Eastern time (2:00
p.m. Pacific time) to review the company’s financial results and
business outlook.
The call is open to all interested investors through a live
audio broadcast via the Internet at www.cardiogenesis.com.
The call also will be available to investors and analysts by
dialing (866) 783-2145 within the U.S. and Canada and (857)
350-1604 from abroad. The passcode is 25300206.
The webcast will be archived on the company’s web site and will
be available for playback for seven days beginning shortly after
the live webcast. A telephonic playback of the conference
call will be available beginning at 8:00 p.m. Eastern time on
Wednesday, November 3, 2010, and continue through 8:00 p.m. Eastern
time on Wednesday, November 10, 2010. The replay can be
accessed by calling (888) 286-8010 within the U.S. and Canada and
(617) 801-6888 from abroad. The replay passcode is
55199188.
About Cardiogenesis Corporation
Cardiogenesis is a medical device company specializing in the
treatment of cardiovascular disease and is a leader in devices that
stimulate cardiac angiogenesis. The company’s market leading
Holmium:YAG laser system and disposable fiber-optic accessories are
used to perform a FDA-cleared surgical procedure known as
Transmyocardial Revascularization (TMR) to treat patients suffering
from angina. Surgical products and accessories for the
Cardiogenesis TMR procedure, which are marketed in the U.S. and
around the world, have been sh
‘/>”/>
SOURCE